Healthcare Providers in the U.S.: Considerations for Commercial Due Diligence

Healthcare remains an active space for private equity investors due, in no small part, to moderate to no cyclicality character and the durable commercial pressure for improvements in both patient outcomes and operating efficiency. In this video, Associate Partner Lynt Johnson, MD discusses key considerations for conducting Commercial Due Diligence in this space, in the U.S., including examining the labor pool and continued labor shortage, the regulatory mix and state-by-state considerations, the payor mix, and the makeup of services, among others.